Chemical inhibitors of ZNF516 include a diverse array of compounds that interact with various cellular signaling pathways and molecular mechanisms to inhibit the function of this protein. Staurosporine, a well-known kinase inhibitor, can directly inhibit the phosphorylation of ZNF516, an essential post-translational modification required for ZNF516's activation and DNA-binding ability. Similarly, the PI3K inhibitors LY294002 and Wortmannin can prevent the phosphorylation and subsequent activation of AKT, which, if involved in phosphorylating ZNF516, would lead to reduced activity of ZNF516. The compound U0126 and PD98059, both MEK inhibitors, can lead to a decrease in the ERK pathway activity, potentially disrupting the ERK-mediated phosphorylation on which ZNF516 may depend for its regulatory functions. Furthermore, SB203580, which inhibits p38 MAPK, could disrupt pathways in which ZNF516 is involved, particularly those dependent on p38 MAPK for stress responses and cytokine production.
Additionally, KN-93, an inhibitor of CaMKII, can disrupt calcium/calmodulin-dependent signaling pathways, which could be integral for ZNF516's function if ZNF516 is regulated by such pathways. Trichostatin A, a histone deacetylase inhibitor, can modify chromatin structure and potentially limit the access of ZNF516 to its DNA binding sites, thus inhibiting its role in transcriptional regulation. MG132, a proteasome inhibitor, might lead to the accumulation of regulatory proteins that inhibit ZNF516's function due to the prevention of their degradation. SP600125, a JNK inhibitor, can suppress JNK signaling, potentially disrupting JNK-mediated phosphorylation processes necessary for ZNF516's activity. Lastly, Palbociclib, a CDK4/6 inhibitor, can maintain retinoblastoma protein in an unphosphorylated state, thereby inhibiting the phosphorylation and activation of ZNF516. Each of these compounds interacts with the signaling networks and molecular processes that are crucial for the proper function of ZNF516, leading to its inhibition.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
As a potent kinase inhibitor, Staurosporine can inhibit the phosphorylation of ZNF516, which is necessary for its activation and subsequent DNA binding. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
By inhibiting mTOR, Rapamycin can suppress the downstream signaling that may be essential for ZNF516's role in regulating gene expression linked to cell growth and proliferation. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
This PI3K inhibitor can reduce AKT phosphorylation, which in turn might inhibit phosphorylation-dependent activation of ZNF516. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
Acting as a MEK inhibitor, PD98059 can inhibit ERK phosphorylation, which could be crucial for ZNF516's function in signaling pathways that regulate gene expression. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126 inhibits MEK, potentially leading to decreased ERK activity and thereby inhibiting the ERK-mediated phosphorylation of ZNF516 that could be required for its activity. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
Inhibits p38 MAPK, which could disrupt signaling pathways involving ZNF516, specifically those that depend on p38 MAPK's role in stress responses and cytokine production. | ||||||
KN-93 | 139298-40-1 | sc-202199 | 1 mg | $182.00 | 25 | |
As a CaMKII inhibitor, KN-93 could inhibit calcium/calmodulin-dependent signaling pathways, thereby potentially inhibiting ZNF516's function if it is regulated by such pathways. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Histone deacetylase inhibitor that can alter chromatin structure, potentially inhibiting the access of ZNF516 to its DNA binding sites, thus inhibiting its transcriptional regulatory function. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
By inhibiting PI3K, Wortmannin can prevent the activation of AKT, potentially inhibiting any AKT-mediated phosphorylation of ZNF516 required for its activity. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
Proteasome inhibitor that can increase cellular protein levels, potentially leading to an increase in regulatory proteins that inhibit ZNF516's function. | ||||||